Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Links

Contact
About
Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With HER2-low Advanced Breast Cancer Treated With T-DXd”

4 trials

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Showing 4 of 4 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07543536

What this trial is testing

Megestrol Acetate for Fatigue Management in T-DXd Treated Breast Cancer

Who this might be right for

Advanced/Metastatic Breast CancerHER2+, Low, or Ultralow Advanced/Metastatic Breast Cancer

Sun Yat-sen University 132

Not applicableEnrolling By InvitationNCT07132749

What this trial is testing

NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd

Who this might be right for

Patients With HER2-positive Advanced Breast Cancer Treated With T-DXdPatients With HER2-low Advanced Breast Cancer Treated With T-DXd

Yeon Hee Park 100

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05953168

What this trial is testing

T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients

Who this might be right for

Triple-Negative Breast Cancer

Fudan University 69

Not applicableNot Yet RecruitingNCT07035353

What this trial is testing

A Real-world Clinical Study of T-DXd for the Treatment of Chinese Patients With HER2 Overexpressing and HER2 Underexpressing Advanced Breast Cancer

Who this might be right for

HER2 OverexpressionAdvanced Stage Breast CancerLow Expression of HER2

Tianjin Medical University Cancer Institute and Hospital 200